Luspatercept + Darbepoetin in MDS

Clinical trial NCT07096297 · RECRUITING

Trial details

NCT number: NCT07096297
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

MDS (Myelodysplastic Syndrome)

Start date: 2025-12-16
Primary completion: 2030-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.